Background Respiratory syncytial virus (RSV) is an increasinglyrecognized cause of illness in adults. Data on the epidemiologyand clinical effects in community-dwelling elderly persons andhigh-risk adults can help in assessing the need for vaccinedevelopment.
Methods During four consecutive winters, we evaluated all respiratoryillnesses in prospective cohorts of healthy elderly patients(65 years of age) and high-risk adults (those with chronic heartor lung disease) and in patients hospitalized with acute cardiopulmonaryconditions. RSV infection and influenza A were diagnosed onthe basis of culture, reverse-transcriptase polymerase chainreaction, and serologic studies.
Results A total of 608 healthy elderly patients and 540 high-riskadults were enrolled in prospective surveillance, and 1388 hospitalizedpatients were enrolled. A total of 2514 illnesses were evaluated.RSV infection was identified in 102 patients in the prospectivecohorts and 142 hospitalized patients, and influenza A was diagnosedin 44 patients in the prospective cohorts and 154 hospitalizedpatients. RSV infection developed annually in 3 to 7 percentof healthy elderly patients and in 4 to 10 percent of high-riskadults. Among healthy elderly patients, RSV infection generatedfewer office visits than influenza; however, the use of healthcare services by high-risk adults was similar in the two groups.In the hospitalized cohort, RSV infection and influenza A resultedin similar lengths of stay, rates of use of intensive care (15percent and 12 percent, respectively), and mortality (8 percentand 7 percent, respectively). On the basis of the diagnosticcodes of the International Classification of Diseases, 9th Revision,Clinical Modification at discharge, RSV infection accountedfor 10.6 percent of hospitalizations for pneumonia, 11.4 percentfor chronic obstructive pulmonary disease, 5.4 percent for congestiveheart failure, and 7.2 percent for asthma.
Conclusions RSV infection is an important illness in elderlyand high-risk adults, with a disease burden similar to thatof nonpandemic influenza A in a population in which the prevalenceof vaccination for influenza is high. An effective RSV vaccinemay offer benefits for these adults.
Source Information
From the Department of Medicine, Rochester General Hospital (A.R.F., P.A.H., M.A.F., E.E.W.) and the Department of Medicine, University of Rochester School of Medicine and Dentistry (A.R.F., E.E.W.) — both in Rochester, N.Y.; and the Division of Epidemiology, Statistics, and Prevention Research, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md. (C.C.).
Address reprint requests to Dr. Falsey at the Infectious Diseases Unit, Rochester General Hospital, 1425 Portland Ave., Rochester, NY 14621, or at ann.falsey{at}viahealth.org.
Murawski, M. R., McGinnes, L. W., Finberg, R. W., Kurt-Jones, E. A., Massare, M. J., Smith, G., Heaton, P. M., Fraire, A. E., Morrison, T. G.
(2010). Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology. J. Virol.
84: 1110-1123
[Abstract][Full Text]
Numata, M., Chu, H. W., Dakhama, A., Voelker, D. R.
(2010). Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection. Proc. Natl. Acad. Sci. USA
107: 320-325
[Abstract][Full Text]
Kohlmann, R., Schwannecke, S., Tippler, B., Ternette, N., Temchura, V. V., Tenbusch, M., Uberla, K., Grunwald, T.
(2009). Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus. J. Virol.
83: 12601-12610
[Abstract][Full Text]
Dodd, J. S., Lum, E., Goulding, J., Muir, R., Van Snick, J., Openshaw, P. J. M.
(2009). IL-9 Regulates Pathology during Primary and Memory Responses to Respiratory Syncytial Virus Infection. J. Immunol.
183: 7006-7013
[Abstract][Full Text]
Collarini, E. J., Lee, F. E.-H., Foord, O., Park, M., Sperinde, G., Wu, H., Harriman, W. D., Carroll, S. F., Ellsworth, S. L., Anderson, L. J., Tripp, R. A., Walsh, E. E., Keyt, B. A., Kauvar, L. M.
(2009). Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients. J. Immunol.
183: 6338-6345
[Abstract][Full Text]
Musiyenko, A., Correa, L., Stock, N., Hutchinson, J. H., Lorrain, D. S., Bain, G., Evans, J. F., Barik, S.
(2009). A Novel 5-Lipoxygenase-Activating Protein Inhibitor, AM679, Reduces Inflammation in the Respiratory Syncytial Virus-Infected Mouse Eye. CVI
16: 1654-1659
[Abstract][Full Text]
Alvarez, R., Elbashir, S., Borland, T., Toudjarska, I., Hadwiger, P., John, M., Roehl, I., Morskaya, S. S., Martinello, R., Kahn, J., Van Ranst, M., Tripp, R. A., DeVincenzo, J. P., Pandey, R., Maier, M., Nechev, L., Manoharan, M., Kotelianski, V., Meyers, R.
(2009). RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy. Antimicrob. Agents Chemother.
53: 3952-3962
[Abstract][Full Text]
Groskreutz, D. J., Monick, M. M., Babor, E. C., Nyunoya, T., Varga, S. M., Look, D. C., Hunninghake, G. W.
(2009). Cigarette Smoke Alters Respiratory Syncytial Virus-Induced Apoptosis and Replication. Am. J. Respir. Cell Mol. Bio.
41: 189-198
[Abstract][Full Text]
Lukens, M. V., Kruijsen, D., Coenjaerts, F. E. J., Kimpen, J. L. L., van Bleek, G. M.
(2009). Respiratory Syncytial Virus-Induced Activation and Migration of Respiratory Dendritic Cells and Subsequent Antigen Presentation in the Lung-Draining Lymph Node. J. Virol.
83: 7235-7243
[Abstract][Full Text]
Chen, L., Song, W., Davis, I. C., Shrestha, K., Schwiebert, E., Sullender, W. M., Matalon, S.
(2009). Inhibition of Na+ Transport in Lung Epithelial Cells by Respiratory Syncytial Virus Infection. Am. J. Respir. Cell Mol. Bio.
40: 588-600
[Abstract][Full Text]
Walsh, E. E., Peterson, D. R., Falsey, A. R.
(2008). Human Metapneumovirus Infections in Adults: Another Piece of the Puzzle. Arch Intern Med
168: 2489-2496
[Abstract][Full Text]
Castro, S. M., Kolli, D., Guerrero-Plata, A., Garofalo, R. P., Casola, A.
(2008). Cigarette Smoke Condensate Enhances Respiratory Syncytial Virus-Induced Chemokine Release by Modulating NF-kappa B and Interferon Regulatory Factor Activation. Toxicol Sci
106: 509-518
[Abstract][Full Text]
Olson, M. R., Hartwig, S. M., Varga, S. M.
(2008). The Number of Respiratory Syncytial Virus (RSV)-Specific Memory CD8 T Cells in the Lung Is Critical for Their Ability to Inhibit RSV Vaccine-Enhanced Pulmonary Eosinophilia. J. Immunol.
181: 7958-7968
[Abstract][Full Text]
Sethi, S., Murphy, T. F.
(2008). Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease. NEJM
359: 2355-2365
[Full Text]
Seemungal, T., Sykes, A., and the ICEAD Contributors,
(2008). Recent advances in exacerbations of COPD. Thorax
63: 850-852
[Full Text]
Munir, S., Le Nouen, C., Luongo, C., Buchholz, U. J., Collins, P. L., Bukreyev, A.
(2008). Nonstructural Proteins 1 and 2 of Respiratory Syncytial Virus Suppress Maturation of Human Dendritic Cells. J. Virol.
82: 8780-8796
[Abstract][Full Text]
Li, D., Jans, D. A., Bardin, P. G., Meanger, J., Mills, J., Ghildyal, R.
(2008). Association of Respiratory Syncytial Virus M Protein with Viral Nucleocapsids Is Mediated by the M2-1 Protein. J. Virol.
82: 8863-8870
[Abstract][Full Text]
Kota, S., Sabbah, A., Chang, T. H., Harnack, R., Xiang, Y., Meng, X., Bose, S.
(2008). Role of Human {beta}-Defensin-2 during Tumor Necrosis Factor-{alpha}/NF-{kappa}B-mediated Innate Antiviral Response against Human Respiratory Syncytial Virus. J. Biol. Chem.
283: 22417-22429
[Abstract][Full Text]
Hui, D S, Woo, J, Hui, E, Foo, A, Ip, M, To, K-W, Cheuk, E S C, Lam, W-Y, Sham, A, Chan, P K S
(2008). Influenza-like illness in residential care homes: a study of the incidence, aetiological agents, natural history and health resource utilisation. Thorax
63: 690-697
[Abstract][Full Text]
Mohapatra, S. S., Boyapalle, S.
(2008). Epidemiologic, Experimental, and Clinical Links between Respiratory Syncytial Virus Infection and Asthma. Clin. Microbiol. Rev.
21: 495-504
[Abstract][Full Text]
Sandrock, C., Stollenwerk, N.
(2008). Acute Febrile Respiratory Illness in the ICU: Reducing Disease Transmission. Chest
133: 1221-1231
[Abstract][Full Text]
Tregoning, J. S., Yamaguchi, Y., Harker, J., Wang, B., Openshaw, P. J. M.
(2008). The Role of T Cells in the Enhancement of Respiratory Syncytial Virus Infection Severity during Adult Reinfection of Neonatally Sensitized Mice. J. Virol.
82: 4115-4124
[Abstract][Full Text]
Nichols, W. G., Peck Campbell, A. J., Boeckh, M.
(2008). Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances. Clin. Microbiol. Rev.
21: 274-290
[Abstract][Full Text]
Ward, T. M., Traina-Dorge, V., Davis, K. A., Gray, W. L.
(2008). Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic. J. Gen. Virol.
89: 741-750
[Abstract][Full Text]
Elliot, A. J., Cross, K. W., Fleming, D. M.
(2008). Acute respiratory infections and winter pressures on hospital admissions in England and Wales 1990-2005. J Public Health (Oxf)
30: 91-98
[Abstract][Full Text]
Collins, P. L., Graham, B. S.
(2008). Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis. J. Virol.
82: 2040-2055
[Full Text]
Castilow, E. M., Olson, M. R., Meyerholz, D. K., Varga, S. M.
(2008). Differential Role of Gamma Interferon in Inhibiting Pulmonary Eosinophilia and Exacerbating Systemic Disease in Fusion Protein-Immunized Mice Undergoing Challenge Infection with Respiratory Syncytial Virus. J. Virol.
82: 2196-2207
[Abstract][Full Text]
Castilow, E. M., Meyerholz, D. K., Varga, S. M.
(2008). IL-13 Is Required for Eosinophil Entry into the Lung during Respiratory Syncytial Virus Vaccine-Enhanced Disease. J. Immunol.
180: 2376-2384
[Abstract][Full Text]
Pletneva, L. M., Haller, O., Porter, D. D., Prince, G. A., Blanco, J. C. G.
(2008). Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats. J. Gen. Virol.
89: 261-270
[Abstract][Full Text]
Jansen, A. G. S. C., Sanders, E. A. M., Hoes, A. W., van Loon, A. M., Hak, E.
(2007). Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J
30: 1158-1166
[Abstract][Full Text]
Treanor, J. D.
(2007). Influenza -- The Goal of Control. NEJM
357: 1439-1441
[Full Text]
Peebles, R. S. Jr., Moore, M. L.
(2007). A Mechanistic Advance in Understanding RSV Pathogenesis, but Still a Long Way from Therapy. Am. J. Respir. Cell Mol. Bio.
37: 375-377
[Full Text]
Anzueto, A., Sethi, S., Martinez, F. J.
(2007). Exacerbations of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc
4: 554-564
[Abstract][Full Text]
Davis, I. C., Lazarowski, E. R., Chen, F.-P., Hickman-Davis, J. M., Sullender, W. M., Matalon, S.
(2007). Post-Infection A77-1726 Blocks Pathophysiologic Sequelae of Respiratory Syncytial Virus Infection. Am. J. Respir. Cell Mol. Bio.
37: 379-386
[Abstract][Full Text]
Liu, B., Kimura, Y.
(2007). Local immune response to respiratory syncytial virus infection is diminished in senescence-accelerated mice. J. Gen. Virol.
88: 2552-2558
[Abstract][Full Text]
Chapman, J., Abbott, E., Alber, D. G., Baxter, R. C., Bithell, S. K., Henderson, E. A., Carter, M. C., Chambers, P., Chubb, A., Cockerill, G. S., Collins, P. L., Dowdell, V. C. L., Keegan, S. J., Kelsey, R. D., Lockyer, M. J., Luongo, C., Najarro, P., Pickles, R. J., Simmonds, M., Taylor, D., Tyms, S., Wilson, L. J., Powell, K. L.
(2007). RSV604, a Novel Inhibitor of Respiratory Syncytial Virus Replication. Antimicrob. Agents Chemother.
51: 3346-3353
[Abstract][Full Text]
Davis, I. C., Xu, A., Gao, Z., Hickman-Davis, J. M., Factor, P., Sullender, W. M., Matalon, S.
(2007). Respiratory syncytial virus induces insensitivity to beta-adrenergic agonists in mouse lung epithelium in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol.
293: L281-L289
[Abstract][Full Text]
Hall, C. B.
(2007). Therapy for Bronchiolitis: When Some Become None. NEJM
357: 402-404
[Full Text]
Min, D., Panoskaltsis-Mortari, A., Kuro-o, M., Hollander, G. A., Blazar, B. R., Weinberg, K. I.
(2007). Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood
109: 2529-2537
[Abstract][Full Text]
Martinez, I., Lombardia, L., Garcia-Barreno, B., Dominguez, O., Melero, J. A.
(2007). Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells. J. Gen. Virol.
88: 570-581
[Abstract][Full Text]
Wedzicha, J A, Hurst, J R
(2007). Chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism. Thorax
62: 103-104
[Full Text]
Wang, H., Peters, N., Schwarze, J.
(2006). Plasmacytoid Dendritic Cells Limit Viral Replication, Pulmonary Inflammation, and Airway Hyperresponsiveness in Respiratory Syncytial Virus Infection. J. Immunol.
177: 6263-6270
[Abstract][Full Text]
Lorber, B.
(2006). Update in infectious diseases.. ANN INTERN MED
145: 354-360
[Full Text]
Wang, H., Peters, N., Laza-Stanca, V., Nawroly, N., Johnston, S. L., Schwarze, J.
(2006). Local CD11c+ MHC Class II- Precursors Generate Lung Dendritic Cells during Respiratory Viral Infection, but Are Depleted in the Process. J. Immunol.
177: 2536-2542
[Abstract][Full Text]
Martin, D., Calder, L. J., Garcia-Barreno, B., Skehel, J. J., Melero, J. A.
(2006). Sequence elements of the fusion peptide of human respiratory syncytial virus fusion protein required for activity. J. Gen. Virol.
87: 1649-1658
[Abstract][Full Text]
Chi, B., Dickensheets, H. L., Spann, K. M., Alston, M. A., Luongo, C., Dumoutier, L., Huang, J., Renauld, J.-C., Kotenko, S. V., Roederer, M., Beeler, J. A., Donnelly, R. P., Collins, P. L., Rabin, R. L.
(2006). Alpha and Lambda Interferon Together Mediate Suppression of CD4 T Cells Induced by Respiratory Syncytial Virus. J. Virol.
80: 5032-5040
[Abstract][Full Text]
Smit, J. J., Rudd, B. D., Lukacs, N. W.
(2006). Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. JEM
203: 1153-1159
[Abstract][Full Text]
Douville, R. N., Bastien, N., Li, Y., Pochard, P., Simons, F. E. R., HayGlass, K. T.
(2006). Human Metapneumovirus Elicits Weak IFN-{gamma} Memory Responses Compared with Respiratory Syncytial Virus. J. Immunol.
176: 5848-5855
[Abstract][Full Text]
Williams, O. W., Sharafkhaneh, A., Kim, V., Dickey, B. F., Evans, C. M.
(2006). Airway Mucus: From Production to Secretion. Am. J. Respir. Cell Mol. Bio.
34: 527-536
[Abstract][Full Text]
Wilkinson, T. M. A., Donaldson, G. C., Johnston, S. L., Openshaw, P. J. M., Wedzicha, J. A.
(2006). Respiratory Syncytial Virus, Airway Inflammation, and FEV1 Decline in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med.
173: 871-876
[Abstract][Full Text]
Glezen, W P., Simonsen, L.
(2006). Commentary: Benefits of influenza vaccine in US elderly--new studies raise questions. Int J Epidemiol
35: 352-353
[Full Text]
Borek, A. P., Clemens, S. H., Gaskins, V. K., Aird, D. Z., Valsamakis, A.
(2006). Respiratory Syncytial Virus Detection by Remel Xpect, Binax Now RSV, Direct Immunofluorescent Staining, and Tissue Culture. J. Clin. Microbiol.
44: 1105-1107
[Abstract][Full Text]
Sapey, E, Stockley, R A
(2006). COPD exacerbations {middle dot} 2: Aetiology.. Thorax
61: 250-258
[Abstract][Full Text]
Harcourt, J., Alvarez, R., Jones, L. P., Henderson, C., Anderson, L. J., Tripp, R. A.
(2006). Respiratory Syncytial Virus G Protein and G Protein CX3C Motif Adversely Affect CX3CR1+ T Cell Responses. J. Immunol.
176: 1600-1608
[Abstract][Full Text]
Rudd, B. D., Smit, J. J., Flavell, R. A., Alexopoulou, L., Schaller, M. A., Gruber, A., Berlin, A. A., Lukacs, N. W.
(2006). Deletion of TLR3 Alters the Pulmonary Immune Environment and Mucus Production during Respiratory Syncytial Virus Infection. J. Immunol.
176: 1937-1942
[Abstract][Full Text]
Trento, A., Viegas, M., Galiano, M., Videla, C., Carballal, G., Mistchenko, A. S., Melero, J. A.
(2006). Natural History of Human Respiratory Syncytial Virus Inferred from Phylogenetic Analysis of the Attachment (G) Glycoprotein with a 60-Nucleotide Duplication. J. Virol.
80: 975-984
[Abstract][Full Text]
Fry, A. M., Shay, D. K., Holman, R. C., Curns, A. T., Anderson, L. J.
(2005). Trends in Hospitalizations for Pneumonia Among Persons Aged 65 Years or Older in the United States, 1988-2002. JAMA
294: 2712-2719
[Abstract][Full Text]
de Bree, G. J., van Leeuwen, E. M.M., Out, T. A., Jansen, H. M., Jonkers, R. E., van Lier, R. A.W.
(2005). Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. JEM
202: 1433-1442
[Abstract][Full Text]
Gorelick, K. J., Simonsen, L., Viboud, C., Falsey, A. R., Walsh, E. E.
(2005). Respiratory Syncytial Virus Infection in Elderly Adults. NEJM
353: 422-423
[Full Text]
(2005). RSV: An Important Pathogen in Elderly and High-Risk Adults. JWatch Infect. Diseases
2005: 1-1
[Full Text]
(2005). RSV Infection Is Common in Older Adults. JWatch General
2005: 5-5
[Full Text]
Sethi, S., Murphy, T. F.
(2005). RSV Infection -- Not for Kids Only. NEJM
352: 1810-1812
[Full Text]
65 years of age) and high-risk adults (those with chronic heart or lung disease) and in patients hospitalized with acute cardiopulmonary conditions. RSV infection and influenza A were diagnosed on the basis of culture, reverse-transcriptase polymerase chain reaction, and serologic studies. 
Previous
